Ge L, Liu L, Wei H, Du L, Chen S, Huang Y, et al
11 Related Stories GLP-1 receptor agonists may increase hair loss risk Medically tailored grocery deliveries improve blood sugar control among diabetes patients Muscle health plays crucial role in diabetes risk, study finds The cardiovascular benefits of semaglutide are attributed to several mechanisms beyond weight loss
Yun, Y.-R
The injectable versus oral peptides comparison breaks down the practical differences in detail
doi:10.1056/NEJMoa1901118 48
Newer agents appear to be more effective at A1c and weight lowering, and its a very exciting time for the treatment of type 2 diabetes and obesity when the new GLP-1 agonists are able to achieve more robust A1c lowering than any other existing diabetes medication other than insulin, she told Healthline